市场调查报告书
商品编码
1435046
美容医学市场:按产品类型、性别和最终用户 - 2024-2030 年全球预测Aesthetic Medicine Market by Products (Body Contouring Devices, Cosmetic Implants, Facial Aesthetic Products), Type (Invasive Procedures, Non-Invasive Procedures), Gender, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年美容医学市场规模为818.1亿美元,预计2024年将达到915.9亿美元,2030年将达到1846.5亿美元,复合年增长率为12.33%。
全球美容医学市场
主要市场统计 | |
---|---|
基准年[2023] | 818.1亿美元 |
预测年份 [2024] | 915.9亿美元 |
预测年份 [2030] | 1846.5亿美元 |
复合年增长率(%) | 12.33% |
美容医学是一个快速发展的多学科领域,涵盖各种医疗程序,透过微创或非侵入性程序增强患者的外表、自尊和整体幸福感。这种专业的医疗实践将艺术与最新的科学进步相结合,解决与老龄化、皮肤健康、身体轮廓和脸部美容相关的各种问题。整容手术设备和技术的技术进步,以及对非侵入性整容手术日益增长的需求,正在加速对美容医学的需求。然而,有限的保险报销范围和严格的监管指南是扩大这些治疗方法使用的障碍。该领域的先进研究和开发促进了创新美容医疗产品的开发,这些产品具有更高的安全性和最短的术后停机时间。市场参与者正在整合远端医疗平台和虚拟咨询等数位技术,以覆盖更多人,同时提高患者便利性。
区域洞察
由于知名製造商的不断增加以及促进创新和产品开拓的竞争环境,美洲是一个成熟的美容医学市场。在美国和加拿大,人们对各种非手术治疗方法(例如注射和塑身产品)的认识不断增强,推动了该地区对美容医学的需求。在美容标准和中阶可支配收入不断增长等文化因素的推动下,亚太地区 (APAC) 对美容医学的需求正在快速增长。特别是韩国、中国和日本的消费者正在优先考虑注重抗老化功效的护肤品,从而改善了美容医学市场。欧洲在皮肤病学研究方面拥有悠久的传统,导緻美容医学的创新。国际医疗旅游正在扩展到波兰、匈牙利和捷克共和国等国家,让患者以低廉的价格获得高品质的照护。欧洲药品管理局 (EMA) 在监督欧盟境内美容医疗产品的市场授权方面发挥着重要作用。
FPNV定位矩阵
FPNV定位矩阵对于评估美容医学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对美容医学市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-美容医学市场的市场规模和预测是多少?
2-美容医学市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3-美容医学市场的技术趋势和法律规范是什么?
4-美容医学市场主要厂商的市场占有率是多少?
5-进入美容医学市场的合适型态和策略手段是什么?
[183 Pages Report] The Aesthetic Medicine Market size was estimated at USD 81.81 billion in 2023 and expected to reach USD 91.59 billion in 2024, at a CAGR 12.33% to reach USD 184.65 billion by 2030.
Global Aesthetic Medicine Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 81.81 billion |
Estimated Year [2024] | USD 91.59 billion |
Forecast Year [2030] | USD 184.65 billion |
CAGR (%) | 12.33% |
Aesthetic medicine, also known as cosmetic medicine, is a rapidly growing interdisciplinary field encompassing various medical practices to enhance the patient's appearance, self-esteem, and overall well-being through minimally invasive or non-invasive procedures. This specialized medical practice combines artistry with the latest scientific advancements to address an array of concerns related to aging, skin health, body contouring, and facial aesthetics. Technological advancements in cosmetic surgery equipment and techniques and increasing demand for non-invasive cosmetic procedures have accelerated the need for aesthetic medicines. However, limited reimbursement coverage and strict regulatory guidelines can act as barriers to increasing the use of these medicines. Advanced research in the field has led to the development of innovative aesthetic medicine products with improved safety profiles and minimal downtime post-procedure. Market players are working on integrating digital technologies such as telemedicine platforms or virtual consultations to help reach a wider audience while improving patient convenience.
Regional Insights
The Americas portrays a well-established aesthetic medicine market driven by the increased presence of well-known manufacturers, creating a competitive environment that fuels innovation and product development. Increased awareness about various non-surgical treatments, such as injectables and body contouring products in the U.S. and Canada, has accelerated the demand for aesthetic medicine in the region. In Asia-Pacific (APAC), the demand for aesthetic medicine is rapidly growing due to cultural factors such as beauty standards and increasing disposable incomes among middle-class populations. In particular, South Korean, Chinese, and Japanese consumers prioritize skincare products focusing on anti-aging benefits, creating an improved market for aesthetic medicine. Europe boasts a strong tradition of excellence in dermatology research, leading to innovations within aesthetic medicine over time. International medical tourism to countries such as Poland, Hungary, and the Czech Republic has expanded, where patients can access high-quality treatments at a lower cost. The European Medicines Agency (EMA) plays a crucial role in overseeing market authorization for aesthetic medicine products within the European Union.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Aesthetic Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aesthetic Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Aesthetic Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd., Bioxis Pharmaceuticals, Black & Black Surgical, Inc., BTL Industries, Candela Corporation, Cutera, Inc., Cynosure Inc., Cytrellis, Inc., Dimeda Instrumente GmBH, Fotona d.o.o., Galderma SA, Inmode Ltd., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Lumenis Be Ltd. by Boston Scientific Corp., Lutronic Inc., Lynton Lasers Ltd., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Millennium Surgical Corp., miraDry, Inc., Quanta System S.p.A. by El.En. S.p.A., Sciton, Inc., Sientra, Inc., Sinclair Pharma Ltd., Solta Medical, Strata Skin Sciences, Venus Concept, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Aesthetic Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aesthetic Medicine Market?
3. What are the technology trends and regulatory frameworks in the Aesthetic Medicine Market?
4. What is the market share of the leading vendors in the Aesthetic Medicine Market?
5. Which modes and strategic moves are suitable for entering the Aesthetic Medicine Market?